Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells  by Liao, Jing et al.
Cell Stem Cell
Brief ReportGeneration of Induced Pluripotent
Stem Cell Lines from Adult Rat Cells
Jing Liao,1,4 Chun Cui,1,4 Siye Chen,1 Jiangtao Ren,1 Jijun Chen,1 Yuan Gao,1 Hui Li,2 Nannan Jia,1 Lu Cheng,1
Huasheng Xiao,3 and Lei Xiao1,*
1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Cell Bank, Stem Cell Bank,
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People’s Republic of China
2Xiangtan Center Hospital, Hunan 411100, People’s Republic of China
3National Engineering Center for Biochip at Shanghai, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203,
People’s Republic of China
4These authors contributed equally to this work
*Correspondence: leixiao@sibs.ac.cn
DOI 10.1016/j.stem.2008.11.013The laboratory rat (Rattus norvegicus) was
the first mammalian species domesti-
cated for scientific research, and it has
been used as an animal model for physiol-
ogy, pharmacology, toxicology, nutrition,
behavior, immunology, and neoplasia for
over 150 years (Jacob, 1999). Despite
this history, the rat lags far behind the
mouse in functional genetic studies and
generation of human disease models be-
cause of the absence of functional germ-
line-competent rat embryonic stem cells
(ESCs), which are vital in reverse genetics
approach. Here, we report the generation
of induced pluripotent stem cells (iPSCs)
from adult rat cells and demonstrate that
the iPSC technique provides a feasible
approach to establish pluripotent stem
cells for a species in which ESCs have
previously proven to be difficult to estab-
lish from the early embryo.
After the first mouse ESC lines were de-
rived 27 years ago (Evans and Kaufman,
1981; Martin, 1981), many efforts were
made to establish rat ESCs, without suc-
cess to date (Brenin et al., 1997; Demers
et al., 2007; Iannaccone et al., 1994; Ma-
shimo et al., 2008; Schulze et al., 2006;
Ueda et al., 2008; Vassilieva et al., 2000).
All of the reported cell lines could only
be termed ESC-like cells because they
did not meet the criteria of ESCs in one
or more of the following aspects: (1) few
cell lines could proliferate for a long period
of time while remaining undifferentiated
and maintaining normal karyotypes; (2)
an advanced teratoma containing all three
germ layers was not reported when the
cells were injected into immune-deficient
mice, suggesting that these rat ESC-like
cells lacked the ability to differentiate
into derivatives of all three germ layers;
and (3) when rat ESC-like cells were in-
jected into a blastocyst, the cells onlycontributed to extraembryonic tissue. No
convincing evidence was reported that
the cells could contribute to other tissues
(Brenin et al., 1997; Demers et al., 2007;
Ueda et al., 2008). These unsuccessful at-
tempts suggest that establishing rat ESCs
from a blastocyst might not be feasible
using traditional methods.
Another type of pluripotent stem cells
called induced pluripotent stem cells
(iPSCs) can be generated by reprogram-
ming adult cells using defined transcrip-
tion factors (Liao et al., 2008; Park et al.,
2008; Takahashi et al., 2007; Takahashi
and Yamanaka, 2006; Yu et al., 2007). Al-
though the first reported mouse iPSCs did
not show germline transmission (Takaha-
shi and Yamanaka, 2006), germline trans-
mission and homologous recombination
were recently demonstrated (Hanna
et al., 2007; Okita et al., 2007; Wernig
et al., 2007). These reports suggest that
iPSCs can replace ESCs in vivo to gener-
ate gene knockout and knockin strains.
Thus, iPSCs could be extremely valuable,
especially for rat and other species in
which ESCs are not available, or difficult
to isolate.
The rat primary ear fibroblast (PEF) or
primary bone marrow (BMC) cells used
in this report were derived from 10-
week-old SD rats. A schematic diagram
of the reprogramming protocol is shown
in Figure 1A, and detailed Experimental
Procedures are included in the Supple-
mental Data online. Virus containing
a cocktail of reprogramming factors was
used to transduce the adult cells. Two
days after transduction, the cells were
harvested by trypsinization and plated
onto MEF (murine embryonic fibroblast
cells) at 5 3 104 cells per well of a six-
well plate. The next day, the medium
(DMEM containing 10% FBS) was re-Cell Stem Ceplaced with medium for ESC culture
(knockout DMEM + 10% FBS + 10% se-
rum replacement without LIF).
First, we tried to use retrovirus contain-
ing SY4 genes (Oct4, Sox2, Klf4, and
c-Myc) to reprogram both adult rat cells
and murine fibroblast cells (as a positive
control). This retroviral transduction
yielded ESC-like colonies from the mouse
cells, and these colonies could be suc-
cessfully expanded (data not shown).
We could also easily transduce the rat
cells with a control retrovirus expressing
EGFP (data not shown), indicating that
the rat cells express the retrovirus recep-
tor. Although the retroviral transduction
could generate a few ESC-like colonies
from the rat cells, these colonies could
not be expanded (data not shown). These
observations suggested that the retroviral
system was not sufficient to generate
ESC-like rat cells from adult rat cells.
We then tried to reprogram the adult rat
cells with lentivirus containing a cocktail
of reprogramming factors. We compared
side by side the efficiency of iPSC pro-
duction by transduction with lentiviral
vectors expressing either SY4 (Oct4,
Sox2, c-Myc, and Klf4 [OSMK]) or JT4
(Oct4, Sox2, Nanog, and Lin28 [OSNL])
genes. We found that the JT4 cocktail
could not generate any alkaline phospha-
tase (AP)-positive colonies, whereas
transduction with the SY4 gene combina-
tion gave rise to a significant number of
AP-positive colonies (Figure 1B).
Colonies with an ESC-like morphology
generated by SY4 genes first became
visible 7 days after transduction. On day
10, the ESC-like colonies were large and
round with clear boundaries (Figure 1Ca).
On day 10, we picked ESC-like colonies
from 50% of the wells, trypsinized them
into single cells, and transferred them toll 4, January 9, 2009 ª2009 Elsevier Inc. 11
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Figure 1. Generation of iPSCs from Rat Primary Ear Fibroblasts and Bone Marrow Cells
(A) Schematic diagram of the reprogramming protocol used.
(B) A comparison of the number of AP-positive ESC-like colonies generated from PEF and BMC by lentiviral transduction of JT4 (OSNL) or SY4 (OSMK) genes;
n = 3. Error bars indicate standard deviation.
(C) iPSCs generated by SY4 viral transduction. (Ca) Typical image of an ESC-like colony. (Cb) Typical image of a non-ESC-like colony. These iPSCs maintain
characteristic mESC-colony morphology (Cc and Cd) and express pluripotency markers, including AP (Ce), SSEA1 (Cf), and Nanog (Cg). (Cd) is a high-magni-
fication view of rat iPSCs. The SSEA1 image (Cf) was acquired by confocal system.
(D) Reverse transcription-PCR analysis of rat iPSC lines, M13 and F65, compared with gene expression observed in parental rat primary cells and rat embryo
cells.
(E) Quantitative reverse transcription-PCR analyses of total (black bars) and endogenous (white bars) Oct4, Sox2, cMyc, and Nanog expression in rat iPSCs
versus parental populations. y axis is defined as the copy number of target gene per 106 copies of GAPDH.
(F) Quantitative reverse transcription-PCR analyses of endogenous Oct4 and Nanog expression in mESC and rat iPSCs relative to parental somatic cell
populations. y axis is defined as the copy number of target gene per 106 copies of GAPDH.12 Cell Stem Cell 4, January 9, 2009 ª2009 Elsevier Inc.
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remaining wells were subjected to AP
staining. The number of AP-positive colo-
nies is shown in Figure 1B. We observed
about 27 and 12 ESC-like colonies re-
programmed by lentiviruses containing
SY4 genes from 5 3 104 PEF or BMC, re-
spectively. The rat ESC-like cells (named
rat iPSCs) could be expanded on MEF
feeder cells with ESC medium. They
formed tightly packed colonies similar to
mouse ESCs (Figures 1Cc and 1Cd).
Each cell exhibited morphology similar
to that of mouse ESCs, characterized by
a high ratio of nucleus to cytoplasm and
prominent nucleoli (Figure 1Cd). The dou-
bling time of rat iPSC line M13 is 11.30 ±
0.67 hr. Plating efficiency is 21.82% ±
1.82%. The doubling time of rat iPSC
line F65 is 10.07 ± 1.05 hr. Plating effi-
ciency is 26.83% ± 1.99%. Rat iPSC line
M13 has now been passaged continu-
ously for more than 36 passages (more
than 3 months). Rat iPSC line F65 has
now been passaged continuously for
more than 38 passages (more than 3
months). Rat iPSCs grew well in the media
without LIF. Under feeder-free conditions,
LIF could not inhibit the differentiation or
maintain the expression of endogenous
Oct4 and Nanog (Figure S1). Therefore,
it might not be appropriate to use LIF as
the key growth factor to derive rat ESCs
from blastocysts, which might partially
explain the unsuccessful establishment
of rat ESCs to date.
Like mouse ESCs, rat iPSCs expressed
AP, stage-specific embryonic antigen
(SSEA)-1, and Nanog protein (Figure 1C).
They did not express hESC-specific sur-
face antigens SSEA-3 or SSEA-4 (data
not shown). RT-PCR showed that rat
iPSCs expressed many undifferentiated
ESC-marker genes, including Oct3/4,
Sox2, Nanog, Nodal, fibroblast growth
factor 4 (FGF4), Gabrb, Gal, Leftyb, and
Lin28 (Figure 1D).
We analyzed the expression of endoge-
nous Oct4, Nanog, and Sox2 and found
that all three were robustly induced, al-
though some of the exogenous genes
were not fully silenced, likely due to the
properties of the lentivirus (Figure 1E).
We used absolute quantitative PCR to
calculate the mRNA copy number ofOct4 and Nanog in both rat iPSCs and
mESCs and found that the expression of
endogenous Oct4 and Nanog in rat iPSCs
was comparable to that in mESCs
(Figure 1F). These observations suggest
that endogenous pluripotency genes
(e.g., oct4 and nanog) can be fully induced
by reprogramming.
To gain a global view of the reprogram-
ming, microarray analysis was performed
to compare the patterns of gene expres-
sion exhibited by rat iPSCs, other pluripo-
tent cells (mouse ESCs and human ESCs),
and nonpluripotent cells. We found the
gene expression profiles of rat iPSC line
F65 and M13 were significantly different
from the adult cells (Tables S4–S6). How-
ever, they are very similar to each other,
despite having been reprogrammed from
different populations of adult cells
(Figure 1G and Tables S4–S6). These ob-
servations suggested that rat iPSC lines
F65 and M13 were reprogrammed to
a similar state. A hierarchical cluster anal-
ysis of 12,355 orthologous genes in rat,
mouse, and human was performed based
on the gene expression profiles. The re-
sults showed that the pluripotent cells, al-
though derived from different species,
cluster together, whereas the nonpluripo-
tent cells cluster separately. This analysis
also revealed that the rat iPSCs cluster
more closely with mouse and human
ESCs than to the nonpluripotent popula-
tions. These data suggested that the rat
iPSCs were reprogrammed faithfully to
pluripotent state similar to that of mouse
and human ESCs. The detailed gene ex-
pression profiles are provided in the
Supplemental Data.
Bisulfite genomic sequencing analyses
of the Oct4 promoter showed that it is
highly unmethylated in rat iPSC clones,
whereas CpG dinucleotides in these re-
gions were highly methylated in parental
PEFs and BMCs (Figure 2A). These results
indicate that the Oct4 promoter is active in
rat iPSCs. Rat iPSCs also showed high
levels of telomerase activity (Figure 2B).
We also performed karyotyping after pas-
sage 15, and our analyses suggested that
the rat iPSC clones showed a normal kar-
yotype of 42XY (Figure 2C).
In order to determine the differentiation
capacity of rat iPSCs in vitro, we allowedCell Stem Cethe rat iPSCs to differentiate for 7 days
and analyzed the presence of differentia-
tion markers. RT-PCR confirmed
that the rat iPSCs could differentiate into
all three germ layers in embryoid
bodies, as evidenced by the expression
of SRY box containing gene 17 (Sox17,
endoderm), AFP (endoderm), MyoD
(mesoderm), SM22-a (mesoderm), NCAM
(ectoderm), and paired box 6 (Pax6,
ectoderm) (Figure 2D). In contrast, endog-
enous Oct3/4, Sox2, and Nanog expres-
sion was markedly decreased (Fig-
ure 2D). These data demonstrate that
iPSCs can differentiate into three germ
layers in vitro.
To test pluripotency in vivo, rat iPSCs
were injected intramuscularly into nonob-
ese diabetic/severe combined immune-
deficient (NOD/SCID) mice. Four weeks
after injection, we observed tumor forma-
tion. Histological examination showed
that the tumor contained various tissues,
including gut-like epithelial tissues (endo-
derm), bone (mesoderm), cartilage (me-
soderm), and neural tissues (ectoderm)
(Figure 2E). The characterizations of rat
iPSCs were summarized in Table S1.
The results presented here have a num-
ber of important implications. First and
most importantly, we demonstrated proof
of principle that the iPSC technique pro-
vides a feasible approach to establish plu-
ripotent stem cells for a species in which
ESCs have proven to be difficult to estab-
lish from the early embryo. Pluripotent
stem cell lines that can proliferate for
long periods of time without differentiation
are vital for targeted gene modification
in vivo (Capecchi, 1989). ESC lines of
many species such as pig, cow, goat,
and sheep are highly desirable, and
many efforts have been invested without
success over the past two decades (Kee-
fer et al., 2007). We propose that the iPSC
technology could be used to generate
pluripotent stem cell lines for species in
which ESC lines are desirable but cannot
be established from the early embryo.
Second, the study of the mechanisms
that maintain stemness based on rat
iPSCs might provide clues for establish-
ing rat ESCs. Although rat and mouse
are both rodents and are similar in many
aspects, it is intriguing that rat ESCs(G) Microarray analysis was performed to compare the gene expression patterns of rat iPSCs, other pluripotent cells (mouse ESCs and human ESCs), and non-
pluripotent populations from each species. The hierarchical cluster analysis of 12355 orthologous genes in rat, mouse, and human was performed based on the
signal ratio. The distances between the samples are shown. Full details of the microarray analysis are available in the Supplemental Data.ll 4, January 9, 2009 ª2009 Elsevier Inc. 13
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Figure 2. The Epigenetic Status and Pluripotency of Rat iPSCs
(A) Bisulfite genomic sequencing of the promoter regions of Oct3/4. Open and closed circles indicate
unmethylated and methylated CpGs, respectively.
(B) Detection of telomerase activity by the TRAP method. Heat-inactivated (+) samples were used as neg-
ative controls.
(C) The rat iPSCs at passage 15 showed a normal 42XY karyotype.
(D) RT-PCR analyses of various differentiation markers for the three germ layers in embryoid body.
(E) Hematoxylin and eosin staining of teratoma derived from rat iPSCs (colony F65). Teratoma (Ea) is
composed of various types of tissues: neuroepithelium (ectoderm) (Eb), cartilage with ossified center (me-
soderm) (Ec), and gut-like epithelium (endoderm) (Ed). (Ee) Magnification of box area in (Ed). (Ef) AFP im-
munostaining for adjacent section in (Ee). Scale bar, 500 mm in (Ea) and (Ec), 100 mm in (Eb) and (Ed)–(Ef).have yet to be established from the early
embryo, despite many attempts. Com-
pared with the previously reported rat
ESC-like cells, the rat iPSCs reported
here exhibit several desirable traits. First,
the rat iPSCs are able to proliferate for
a long period of time, and yet they main-
tain a normal karyotype. Second, the rat
iPSCs can form teratoma-containing tis-
sue from all three germ layers in vivo.14 Cell Stem Cell 4, January 9, 2009 ª2009There could be many reasons that rat
ESC lines have not yet been established.
It could be that the necessary culture con-
ditions required to maintain the stemness
of rat ESCs have not been achieved. The
generation of rat iPSCs, which have simi-
lar properties to ESCs, might allow us to
study the mechanisms that are essential
to maintain the stemness of rat ESCs.
We found that LIF could not maintain theElsevier Inc.expression of endogenous Oct4 and
Nanog in rat iPSCs under feeder-free con-
ditions. Based on the same principle, we
can further characterize the signaling
pathways that regulate the expression of
endogenous Oct4 and Nanog in rat
iPSCs. The data acquired from these
studies might give insight into achieving
the proper culture conditions to derive
rat ESCs from the early embryo.
Finally, the rat iPSCs are able to prolif-
erate for a long period of time without
differentiation. These properties provide
an opportunity for using the homologous
recombination technique in rat iPSCs.
The successful demonstration of germline
transmission and homologous recombi-
nation in mouse iPSCs encourages us to
propose that rat iPSCs might be directly
used to generate knockout and knockin
rats once germline transmission is dem-
onstrated. This could make the rat a pre-
mier model for human diseases. Due to
the unavailability of an efficient rat embry-
onic manipulation system, we have so far
not been able to demonstrate the genera-
tion of chimera from our rat iPSCs. How-
ever, we demonstrated that the rat iPSCs
could proliferate rapidly for long-term and
maintain pluripotency. These observa-
tions suggest that rat iPSCs should be
able to contribute to chimera if an efficient
rat embryonic manipulation system is
available. The remaining challenge is to
establish a protocol to generate chimeric
rats with germline transmission by using
rat iPSCs. Viral integration into the ge-
nome might be temporarily resolved by
backcrossing to wild-type rats six times,
or it might be ultimately resolved by gen-
erating rat iPSCs without vector integra-
tion into the genome.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Ex-
perimental Procedures, ten tables, and three fig-
ures and can be found with this article online at
http://www.cell.com/cell-stem-cell/supplemental/
S1934-5909(08)00615-2.
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